Clay Therapy in Schizophrenia Patients
ConditionSchizophrenia and Related Disorders
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorKutahya Health Sciences University
About this trial
In recent years, art therapies have been discussed for their positive effects on mental disorders. One such therapy, clay therapy, is being studied to examine its effect on the functional recovery and individual and social performance of schizophrenia patients undergoing pharmacological treatment.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Having been diagnosed with schizophrenia,
Being aged 18 or over,
Having completed at least primary school education,
Having achieved treatment compliance,
Disqualifiers
Being under 18 years of age,
Not having an education,
Not having a diagnosis of schizophrenia,
Not adhering to treatment,
Trial design
Design model
Parallel
Treatments tested in this trial
Clay therapy
Other interventionExperimental: Clay therapy group
Treatment groups
17 Participants
are divided into 2 treatment groupsGroup A: Clay therapy groupExperimental treatment 1 intervention
Group B: Routine treatment groupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Functional Recovery Scale for Schizophrenia Patients
This is a 5-point Likert-type scale consisting of 19 items that assesses improvements in functionality independent of the symptoms of the disease. Level 1 (absent) indicates the lowest level of improvement, while Level 5 (present to a high degree) corresponds to the 'ideal' level of function. Level 2 (partially present), Level 3 (sufficiently present) and Level 4 (almost completely present) are also included. When two levels are between, the lower level is selected. The maximum score that can be obtained from the scale is 95, and the minimum score is 19. The scale, which consists of subscales for daily living skills, social functioning, and health and treatment, measures functional improvement in three separate areas.
Time frame
12 weeksSecondary outcomes
1
Individual and Social Performance Scale
This scale, scored from 1 to 100, is conducted in three stages. In the first stage, the level of functionality is determined through a sequential assessment across four dimensions: socially beneficial activities, individual and social relationships, self-care, and disruptive and aggressive behaviours. After each dimension is assessed, it is scored between 0 and 10 points based on the degree of impairment in that dimension.
Time frame
12 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov